1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIDCR Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs is sponsored by National Institute of Dental and Craniofacial Research (NIDCR) / NIH. The NIDCR provides research funds through SBIR and STTR programs to support basic, translational, and clinical research in dental, oral, and craniofacial health and disease, including orofacial pain conditions and neuroscience.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Business Innovation Research/Small Business Technology Transfer Research (SBIR/STTR) Program | National Institute of Dental and Craniofacial Research NIH Websites Are Changing Get the Latest Updates and FAQs Small Business Innovation Research/Small Business Technology Transfer Research (SBIR/STTR) Program Small Business Innovation Research/Small Business Technology Transfer Research (SBIR/STTR) Program Notice of Special Interest (NOSI): Alzheimer's and Alzheimer's-related Dementias (AD/ADRD) Focused Competitive
Revisions to Existing NIH Grants that are not focused on AD/ADRD Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) Innovation Corps (I-Corps TM) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed) Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues
(Admin Supp Clinical Trial Optional) NIDCR Notice of Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)" Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) Notice of Special Interest (NOSI): Advancing Precision Imaging for Enhanced Diagnosis and Treatment of Oral Lesions Notice
of Special Interest (NOSI): HEAL Initiative: Development and Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
According to the current listing, eligibility includes: Small business concerns conducting research in dental, oral, and craniofacial health and disease, including orofacial pain and temporomandibular joint disorders. Confirm the full requirements in the official notice before applying.
The current listing shows not specified; NIH SBIR Phase I up to $323,090, Phase II up to $2,153,927. Verify award ceilings, matching requirements, and allowable costs in the official notice.
NIDCR Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs is funded by National Institute of Dental and Craniofacial Research (NIDCR) / NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article